• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problems Stretched (1601); Defective Device (2588); Patient-Device Incompatibility (2682)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/05/2023
Event Type  malfunction  
Manufacturer Narrative
B3: date of implant estimated as (b)(6) 2023.D4: the udi is unknown because the part/lot numbers were not provided.The device was not returned for analysis.A review of the lot history record and similar incident review of the reported lot could not be conducted because the part and lot numbers were not provided.The investigation determined a conclusive cause for the reported stretched-stent, the reported patient-device incompatibility-recoil and the reported defective device-shortened cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The reported adverse patient effects referenced in b5 are being filed under a separate medwatch report #.Attachment: article titled, 'a systematic review and meta-analysis of supera interwoven nitinol stents for the treatment of infrainguinal peripheral arterial disease'na.
 
Event Description
It was reported through a research article identifying supera that may be related to the following: stenosis, occlusion, dissection, elongation, compression, malapposition, invagination, and amputation.This is a systematic review for articles published from december 2011 up to may 2021 regarding studies assessing the safety and efficacy of supera interwoven nitinol stent for the treatment of infra-inguinal peripheral artery disease.Details are in the attached article titled, "a systematic review and meta-analysis of supera interwoven nitinol stents for the treatment of infrainguinal peripheral arterial disease".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18312639
MDR Text Key330298500
Report Number2024168-2023-13844
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGR
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-